its biological actions can exceed the capacity of the detoxification pathway to prevent the mutagenic episode.
While there is convincing evidence that the initiation of cancer 4 To whom correspondence should be addressed following exposure to environmental toxicants can be attributed Email: rtukey@ucsd.edu to patterns of metabolic activation of pre-carcinogens by microsomal oxidation, detoxification pathways may also play a The importance of environmental and dietary arylamines, and heterocyclic amines in the etiology of human cancer significant role in the metabolic defense against environmental mutagens aimed at facilitating their removal from the cells is of growing interest. These pre-carcinogens are known to undergo bioactivation by cytochrome P450 (CYP)-directed prior to initiation of the mutagenic event. The Phase II families of enzymes involved in conjugation reactions participate in oxidation, which then become substrates for the UDPglucuronosyltransferases (UGTs). Thus, glucuronidation cellular trapping and elimination of potentially harmful metabolic by-products and xenobiotics by forcing the conjugates may contribute to the elimination of CYP-mediated reactive intermediate metabolites, preventing a toxic event. In this into the aqueous compartments enabling elimination through kidney or biliary excretion. The UDP-glucuronosyltransferases study, human UGTs were analyzed for their ability to modulate the mutagenic actions of N-hydroxy-arylamines (UGTs), which as a multigene family share a wide range of substrate specificities (1), have been proven to participate in formed by CYP1A2. Studies with recombinant human UGT1A1, UGT1A3, UGT1A4, UGT1A6, UGT1A7, the conjugation of potentially harmful oxidative products. Recent evidence has indicated that early down-regulation of UGT1A8, UGT1A9, UGT1A10, UGT2B4, UGT2B7 and UGT2B15 expressed in heterologous cell culture confirmed the UGTs in premalignant and malignant tumor tissues but not benign tumors may be a prerequisite of cellular carcinogenesis that UGT1A9 glucuronidated the mutagenic arylamines N-hydroxy-2-acetylaminofluorene (N-hydroxy-2AAF) and (2), indicating that the deregulation of the metabolic and cellular defense mechanisms compromises the normal homeo-2-hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine (N-hydroxy-PhIP). To examine the mutagenic potential of static functions of the cell. At present, 15 human UGTs have been cloned and most these agents, a genotoxicity assay was employed using Salmonella typhimurium NM2009, a bacterial strain have been characterized in terms of functional properties through expression in heterologous cellular systems (1). Along expressing the umuC SOS response gene fused to a β-galactosidase reporter lacZ gene. DNA modification results with the cloning and characterization of the human P450s (4), biological tools are now available to design expression systems in the induction of the umuC gene and subsequent enhancement of β-galactosidase activity. Both N-hydroxy-2AAF
to study the contribution of individual UGTs in the metabolism of potentially harmful oxidative products catalyzed by the and N-hydroxy-PhIP stimulated a dose-dependent increase in bacterial β-galactosidase activity. In addition, the procarCYPs. One class of compounds that contains excellent candidates for the formation of oxidative derived mutagens as well cinogens 2AAF and PhIP were efficiently bioactivated to bacterial mutagens when incubated with Escherichia coli as potential substrates for glucuronidation is the aromatic and heterocyclic amines (arylamines). membranes expressing CYP1A2 and NADPH reductase. CYP1A2 generated 2AAF-and PhIP-mediated DNA damArylamines represent a class of potent bacterial mutagens and are believed to be animal and human carcinogens (5-7). age, but only the action of N-hydroxy-2AAF was blocked by expressed UGT1A9. These results indicate that UGT1A9 N-Hydroxylation of aromatic amines is also correlated with DNA adduct formation in animal studies (8,9), and has been can control the outcome of a genotoxic response. The results also indicate that while a potential toxicant such as shown to initiate chemical mutagenesis in the classical reverse mutation assay described by Ames et al. Oxidative metabolism N-hydroxy-PhIP can serve as substrate for glucuronidation, bioactivates arylamines to potential mutagens through N-hydroxylation (10-13), followed by esterification by which is initiated primarily by microsomal CYP1A2 (13,14-UDPGlcA, uridine 5Ј-diphosphoglucuronic acid; UGT, UDP-glucuronosyltransferase.
20).
from our laboratory using different human tissue RNA (21, 23, 45) , were
Our laboratory has identified and cloned the human UGT1A subcloned into the baculovirus expression plasmid pBlueBac4. In this study, the N-acylarylamine 2-AAF and the heterocycmM MgCl 2 and 1 mM phenylmethysulfonyl fluoride, and the cells were lic amine PhIP were used as model compounds to examine UGT sonicated for 5ϫ5s. The cell lysate was pelleted at 10 000 g for 10 min at 4°C. The cells were re-suspended in the same buffer, sonicated for 5ϫ5s, and metabolism following activation through N-hydroxylation. 2-pelleted at 10 000 g for 10 min at 4°C. The two supernatants were pooled AAF is among the most intensively studied of all genotoxins and centrifuged at 100 000 g for 60 min at 4°C. The microsomal pellet was (11, 27, 28) , while PhIP and other heterocyclic amines are 
CYP1A2 and UGT proteins. A mutagenicity assay was

Identification of human UGT activities
employed that uses Salmonella typhimurium strain NM2009, UGT activities were determined by TLC assay according to the method of which carries a chimera umuC'lacZ (32, 33) . In this assay the Bansal and Gessner (47) . Cells expressing the recombinant UGTs were 
Materials and methods
the activities for the levels of expressed UGT, or as relative values, which Reagents takes into consideration UGT protein abundance. 2-AAF, N-hydroxy-2AAF and PhIP were obtained from the National Cancer UmuC genotoxicity assay Institute Chemical Carcinogen Repository, Midwest Research Institute (Kansas Human CYP1A2 was co-expressed with NADPH-P450 reductase in EscherCity, MO). N-Hydroxy-PhIP was from Toronto Research Chemicals (Toronto, ichia coli using a bicistronic system (pCWЈ1A2:NPR) in which a single Canada). ONGP, UDPGLcA, D-glucose-6-phosphate, β-NAPD, D-glucose-6-mRNA is produced and is translated into two proteins (48) . The bacterial phosphate dehydrogenase and substrates used for analysis of UGT activity were tester strain, S.typhimurium NM2009 (TA1535/pSK1002/pNM12) carried a purchased from Sigma (St Louis, MO). Horseradish peroxidase conjugated fused umuC'lacZ gene. DNA damage by genotoxins induces expression of secondary antibody and the 'Supersignal' chemiluminescent detection kit (for the umuC gene, a gene controlled by SOS response (49) , and subsequently immunoblotting) were from Pierce (Rockford, IL). Bio-Rad Protein Assay for results in expression of β-galactosidase, encoded by the reporter lacZ gene. protein concentration analysis was purchased from Bio-Rad (Hercules, CA).
Additionally, the bacterial O-acetyltransferase gene (in pNM plasmid) was Thin layer chromatography plates were from Whatman (Clifton, NJ). Tristransformed into the original S.typhimurium TA1535/pSK1002 strain, yielding glycine gels for SDS-PAGE were from Novex (San Diego, CA). pcDNA a system that is highly sensitive to the mutagenic actions of heterocyclic/ expression vector was purchased from Invitrogen (Carlsbad, CA).
aromatic amines by generation of N-acetoxy metabolites, which subsequently Production of recombinant baculovirus and heterologous protein expression break down into nitrenium ions (43, 44) . In this model, the genotoxicity of the procarcinogen was dependent upon human CYP1A2 which had been expressed Full length UGT cDNAs encoding UGT1A1, UGT1A3, UGT1A4, UGT1A6, UGT1A7, UGT1A9, UGT1A10, UGT2B4, UGT2B7 and UGT2B15, cloned E.coli, as measured using umuC gene expression. The genotoxicity assay was Figure 1 . For example, the (Bottom) Relative expression levels based upon the expression of UGT1A8. absolute value of UGT1A9 generated N-hydroxy-2AAF activity was Not shown are the abundance levels of UGT2B4, UGT2B7 or UGT2B15. determined by taking the absolute value (2570) and dividing by 0.6. c NA, no activity. expression in HK293 or V79 cells were generated for human to a concentration of~5 mg/ml protein and the expressed 0.5% (w/v) NaCl, 25 µg/ml ampicillin, 10 µg/ml chloramphenicol) until the enzymes were evaluated with the intention of obtaining the bacteria density reached an OD 600 of 0.25-0.3. To achieve the maximum efficiency of metabolic activation by CYP1A2, membrane-containing CYP1A2 most efficient expression system for each UGT. While each was pre-incubated with test compound at 37°C for 20 min, followed by cellular model displayed catalytic activity, we found greater addition of 1.7 ml tester bacteria. The pre-incubation mixture (300 µl) included catalytic activity when UGT1A4, UGT1A6, UGT1A9 and 100 µM potassium phosphate buffer (pH 7.4), E.coli membrane fraction (40- UGT2B4 were expressed in HK293 cells and UGT1A1, 100 µg) containing CYP1A2/NADPH reductase, NADPH generating system (5 mM glucose-6-phosphate, 1 mM β-NADP and 1 U glucose-6-phosphate UGT1A3, UGT1A7, UGT1A8 and UGT1A10 were expressed dehydrogenase) and procarcinogen dissolved in 10 µl DMSO. After 2 h in V79 cells (Table I) . Baculovirus infected insect Sf9 cells vigorously shaking at 37°C, the β-galactosidase assay for mutagenic activity expressed UGT2B7 and UGT2B15 more efficiently than their was examined. The bacterial density were measured at OD 600 and was expression in HK293 and V79 cells. Expressed UGT1A1, used for both normalization of expression levels and indication of cellular cytotoxicity. The genotoxicity data was taken only at OD 600 Ͼ 60% of control UGT1A3, UGT1A4, UGT1A6, UGT1A7, UGT1A8, UGT1A9, group to eliminate cytotoxic effects. A fraction (0.1 ml) of the culture was UGT1A10, UGT2B4 and UGT2B7 were all active with subdiluted with 0.9 ml Z buffer (60 mM Na 2 HPO 4 , 40 mM NaH 2 PO 4 pH 7.0, strates that have previously been determined to elicit maximal 10 mM KCl, 1 mM MgSO 4 , 50 mM 2-mercaptoethanol) and the bacterial glucuronidation activity (1). Examples of activities with control cells were made permeable to the chromogenic substrate for β-galactosidase by adding 0.1% SDS and one drop of chloroform, then mixing vigorously.
substrates are shown in Table I . While significant protein can
The enzyme reaction was initiated by the addition of 0.1 ml 2-nitrophenyl-β-be produced within Sf9 cells infected with a UGT2B15 D-galactopyranoside solution (4.0 mg/ml in 0.1 M sodium phosphate buffer, construct, the extracts express little UGT activity, even with pH 7.0) and incubated at 37°C for 15 min. The reaction was stopped by 4-methylumbilliferone, which had been shown previously to adding 0.5 ml Na 2 CO 3 and the absorbance at OD 420 and OD 550 was measured (32) . be a substrate for expressed UGT2B15 in HK 293 cells (50) .
The ability of UGT metabolism to interrupt the mutagenicity of arylamine Thus, UGT2B15 was not used in additional experiments. The metabolites was examined by directly adding activated mutagen (N-hydroxy cellular preparations that were employed in these studies 2AAF or N-hydroxy PhIP) to a 300 µl reaction mixture containing 50 mM expressed the different UGTs, as demonstrated by immunoblot MgCl 2 , 10 mM Tris-HCl pH 7.2, 500 µM UDPGLcA, 8.5 mM saccharolactone and 100 µg expressed UGT from cell lysates. Following a 60 min preanalysis (Figure 1) . Also shown is an approximation of the incubation, the reaction mixture was centrifuged to eliminate cellular mass relative expression levels, which were determined based upon and the supernatant was added to 1.7 ml bacterial tester strain, then shaken the fraction equivalent of the most abundant UGT (UGT1A8).
at 37°C for 2 h. umuC gene expression was estimated from β-galactosidase
Taking these values into consideration, a second set of catalytic activity. All umuC assays were performed at least twice with duplicate tubes at each concentration of substrate.
activities were generated as shown in Table I . While these relative expression values are important, it should be noted Results that we did not attempt to dilute the cellular preparations for Catalytic activities of expressed guts catalytic analysis based upon the outcome of protein abundance as judged by western blot analysis. Since these are clonal cell Recombinant proteins from heterologous expression systems, including Sf9 expressed recombinant baculovirus or stable lines, we felt it more important that the activities be represented based upon total cellular protein, since this accurately reflects (Table I) . While UGT1A3, UGT1A6, same as group A but with 1 µM of the CYP inhibitor α-naphthoflavone.
UGT1A8, UGT1A10 and UGT2B7 were also active toward N-hydroxy-2AAF, their activities were considerably lower than that for UGT1A7 and UGT1A9. Using extracts for expressed UGT1A7 and UGT1A9, Figure 2 shows the kinetics of N-hydroxy-2AAF glucuronide formation, using a range of substrates from 1 to 400 µM. The UGT1A9 reaction was characterized by a K m of 15 µM and a V max of 370 pmol/min/ mg protein. In comparison, UGT1A7 generated N-hydroxy-2AAF glucuronide with~30% the rate, 138.6 pmol/min/ mg protein.
In previous experiments, our laboratory determined that Nhydroxy-PhIP was glucuronidated by baculovirus-expressed UGT1A9 (21) , with activity also expressed by UGT1A7 and UGT1A10. Similar ratios of activities were observed with extracts from HK293 and V79 cells (Table I) . We also found catalytic activity with V79 expressed UGT1A3 (Table I) , similar to preparations of UGT1A3 expressed in HK293 (26) . In addition, expressed UGT1A1 was also active. Our results are somewhat different than Nowell et al. (26) . It was reported that UGT1A8 was most active for the formation of N-hydroxyPhIP-N 2 -glucuronide with no detectable activity with expressed UGT1A1. The preparation of UGT1A8 used in our experiments contained limited catalytic activity, while UGT1A1 was the most active toward this substrate.
The results of these studies indicate that several of the mutagenic activity of N-hydroxy-2-AAF and N-hydroxy-PhIP.
Induction of umuC gene expression by 2-AAF and PhIP through CYP1A2 metabolism experiments, N-hydroxy-2AAF
and N-hydroxy-PhIP demonstrated in a dose-dependent manner the ability to facilitate A quantitative umuC induction assay was used as a measurement of bioactivation of the aromatic amines. In control the mutagenic response as determined by an increase in is also possible that the efficiency of this reaction far exceeds that of glucuronidation, making it difficult to generate sufficient quantities of the glucuronide such that a reduction in mutagenicity can be elicited.
Discussion
CYP1A2 catalyzed N-hydroxylation of several classes of arylamines leads to the formation of metabolites that have been shown to initiate a mutagenic event. Interestingly, many of the mutagens, such as the dietary heterocyclic amines that are formed by N-hydroxylation, have also been detected as would be expected to reduce the mutagenic activity of the CYP1A2 catalyzed N-hydroxy compounds. To investigate this possibility, two classical bacterial mutagens, 2AAF and PhIP, S.typhimurium NM2009 β-galactosidase activity ( Figures 3A were chosen to examine the potential for human UDP-glucuand 4A). In comparison, a step wise increase in β-galactosidase ronosyltransferases to interrupt the ability of these agents to activity was not observed with 2AAF or PhIP, which are both promote a mutagenic response. considered to be non-mutagenic in the absence of Both 2AAF and PhIP are benign substrates when added to a N-hydroxylation ( Figures 3B and 4B) . Thus, the Nbacterial mutagenic assay, but their N-hydroxylated metabolites hydroxylated metabolites serve as efficient candidates for efficiently induce in a dose-dependent manner bacterial mutaanalysis of mutagenic potential.
genesis using the umuC test in S.typimurium TA1535/pSK1002, To examine the ability of CYP1A2 to catalytically generate as developed previously by Oda et al. (32) . When 2AAF the mutagenic metabolites of 2AAF and PhIP as reported and PhIP are used as substrates and incubated with E.coli previously, the substrates were incubated with an NADPH membranes containing expressed CYP1A2 and the extracts generating system in the presence of membranes containing added to the umuC test, a similar concentration dependent expressed CYP1A2/NADPH reductase. With both 2AAF and increase in bacterial mutagenesis is observed. Since the bioPhIP, a concentration-dependent increase in the mutagenic logical activity of the mutagens results in the formation of an potential of CYP1A2 generated metabolites was observed N-acetoxy metabolite catalyzed by bacterial O-acetyl trans-( Figures 3B and 4B) . The induction of β-galactosidase activity ferases and the interaction of the nitrenium ion with DNA, the in the presence of 2AAF was also inhibited by 1 µM of the relationship between the concentrations of the substrate used CYP1A2 inhibitor, α-naphthoflavone ( Figure 3B ). Based upon in the CYP1A2 reaction and the production of β-galactosidase the specificity of the oxidation reaction from previous experiactivity is a good indicator of the relative concentration of Nments (13), the metabolites are generated through Nhydroxy metabolite. In these experiments, similar concentrahydroxylation.
tions of 2AAF and PhIP lead to comparable mutagenic Inhibition of N-hydroxy 2-AAF genotoxicity by UGT1A9 activity as catalyzed by CYP1A2. While N-hydroxy metabolite concentrations were not determined for 2AAF and PhIP, it can Since it has been confirmed that UGT1A9 is capable of glucuronidating both N-hydroxy-2AAF and N-hydroxy-PhIP, be concluded based upon the dose-response curves that similar levels of the N-hydroxy metabolites are needed to produce experiments were conducted to examine the ability of UGT1A9 to inhibit the genotoxicity of these substrates. Cell lysates comparable mutagenic activity. While considerable data are available on the ability of the containing expressed UGT were used in a genotoxicity assay in S.typhimurium NM2009. In the presence of UDPGLcA, different human UGTs to metabolize endogenous substances as well as xenobiotics and drugs (1), limited information is UGT1A9 inhibited the genotoxicity of N-hydroxy 2-AAF when incubated at a concentration of 25 µM and completely abolished available on the ability of these enzymes to metabolize N-hydroxy metabolites. Our laboratory (21) has recently demgenotoxicity at lower concentrations ( Figure 5 ). In the absence of UDPGLcA or active UGT1A9 extract, there was no inhibionstrated that human UGT1A9 and UGT1A7 are capable of utilizing N-hydroxy-PhIP as substrate to form N-hydroxy tion of mutagenicity. When incubations were performed with 2AAF as substrate in the presence of active CYP1A2 and glucuronides, but at relatively low rates in comparison to the aryl-O-linked phenolic glucuronidation of 7-hydroxybenzo[α]-UGT1A9, a similar profile leading to the inhibition of mutagenesis was observed (data not shown). Thus, the mutagenicity pyrene (21) . It turns out that the glucuronidation of N-hydroxy-2AAF is fairly specific, serving as substrate primarily for of N-hydroxy-2AAF can be blocked by active UGT1A9.
Contrary to the glucuronidation of N-hydroxy 2-AAF, UGT1A7 and UGT1A9 directed glucuronidation, although UGT1A3, UGT1A6, UGT1A8, UGT1A10 and UGT2B7 were UGT1A9 was not able to interfere with the mutagenicity of N-hydroxy-PhIP (data not shown). This may be due to the capable of generating N-hydroxy-2AAF glucuronides but at dramatically reduced rates. The specificity of N-hydroxy-linked dramatic differences in the formation of UGT1A9 generated glucuronide, as calculated from standard catalytic analysis glucuronidation may be a favored reaction for UGT1A7 and UGT1A9, since these enzymes participate in the glucuronid-(N-hydroxy-2AAF is 411 pmol/min/mg protein compared with 56.5 pmol/min/mg protein for N-hydroxy-PhIP). Since the ation of N-hydroxy-2AAF and N-hydroxy-PhIP.
Although N-hydroxy-2AAF and N-hydroxy-PhIP exhibit mutagenic metabolites of N-hydroxy-PhIP are O-esterified acetyl derivatives formed from bacterial acetyltransferase, it comparable mutagenic potential and are glucuronidated by similar UGT isozymes, N-hydroxy-2AAF is conjugated far is an excellent model system to examine the potential mutagenic more efficiently by UGT1A9 than N-hydroxy-PhIP. The lack actions of heterocyclic and aromatic amines (32, 53, 54) , has of comparable levels of glucuronidation is also reflected in the been exploited to study the potential for UGTs to influence ability of UGT1A9 to prevent the N-hydroxy metabolites from the outcome of a patterned biological response such as mutainitiating a mutagenic event in NM2009 cells. Addition of genesis. Coordination between CYP mediated bioactivation comparable concentrations of the N-hydroxy metabolites to and UGT initiated detoxification has been demonstrated, with the umuC test in the presence of active UGT1A9 led to the glucuronidation of CYP1A2 activated N-hydroxy-2AAF dramatic reductions in N-hydroxy-2AAF initiated mutagenicity, leading to the interruption of the mutagenic response. By while little effect was observed when similar experiments were measuring a defined biological end point such as mutagenesis, carried out in the presence of N-hydroxy-PhIP. The ability of this type of experiment allows for the alteration of defined UGT1A9 to attenuate the mutagenic response of N-hydroxyvariables such as protein and substrate concentration, and 2AAF could also be demonstrated in a dose-response fashion within a single measurement, makes it possible to predict using variable concentrations of substrate, indicating that the rate limiting step as controlled through bioactivation or glucuronidation can be rate limiting in uncoupling the mutadetoxification of potential mutagens. In the presence of genic actions of this compound. When incubations are carried toxicants like N-hydroxy-2AAF, glucuronidation is capable of out with mixtures of active CYP1A2 and UGT1A9 in the providing sufficient protection to limit the hazardous effects presence of the pre-mutagens 2AAF and PhIP, UGT1A9 of the metabolite in initiating a mutagenic response. prevents CYP1A2 from generating sufficient unconjugated This is in sharp contrast to the food derived heterocylic N-hydroxy-2AAF, as measured by the lack of SOS response amines. Although PhIP has been shown to be a substrate for in S.typhimuruim NM2009. However, UGT1A9 is not capable human glucuronidation, oxidative metabolism initiated by of disrupting the mutagenic actions of CYP1A2 directed CYP1A2 leads to the formation of metabolites that are predis-N-hydroxylation of PhIP. We can suggest that while glucuronidposed to initiate a mutagenic response while serving as ation plays a role in the metabolism of N-hydroxy-PhIP, the substrates for glucuronidation. While analysis of N-hydroxyefficiency for this reaction is not sufficient under saturating PhIP has shown it to be a substrate for glucuronidation, enzymatic conditions in the presence of CYP1A2 to detoxify UGT1A9 is limited catalytically in protecting the cell from the biologically active mutagen. Thus, bioactivation via the hazardous effects of the mutagen. However, care must be CYP1A2 might be a more dominant pathway than glucuronidtaken in the interpretation of these results, since mutagenic ation initiated detoxification in overall PhIP metabolism.
analysis as carried out in these experiments does not mimic CYP1A2 is expressed primarily in the liver and is the most an in vivo situation as might be encountered in the cell efficient of the P450s in catalyzing the N-hydroxylation of the where a battery of UGT1A proteins may work in concert to dietary heterocyclic amines such as PhIP and IQ (51) . In glucuronidate these substrates. While these results are certainly rodents, it has been demonstrated that PhIP can lead to the preliminary, it would appear the glucuronidation may not be formation of colon cancer and it is speculated that the sufficient to prevent the potential hazardous effects of these N-hydroxy-PhIP produced in the liver may be the mutagen compounds on the cell. responsible for colon-initiated carcinogenesis. This experiment would suggest that CYP1A2 generated N-hydroxylation ofpotential to serve as substrates for glucuronidation are not tially to the metabolism and detoxification of those agents. Res., 376, 211-219.
mediates to target organs. Yet the bacterial umuC test, which
